Weekly Recap | Viking Therap -9.35%, VK2735 advances to Phase 3Weekly Review·1 day ago, 07:04 AMVKTX-1.26%
Weekly Recap | Viking Therap -8.29%, most brokers rate it buyWeekly Review·Sep 12 at 07:07 AMVKTX-1.26%
Weekly Recap | Viking Therap +8.43%, most brokers rate it buyWeekly Review·Sep 5 at 08:24 AMVKTX-1.26%
Weekly Recap | Viking Therap -5.1%, consensus target above spotWeekly Review·Aug 29 at 06:40 AMVKTX-1.26%
